During the past decade, Coastal Carolina Research Center conducted 150 clinical trials. In the 10-year time frame, 150 clinical trials started and 123 clinical trials were completed, i.e. on average, 82% percent of trials that started reached the finish line to date. In the past 5 years, 69 clinical trials started and 84 clinical trials were completed. i.e. 121.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Coastal Carolina Research Center" #1 sponsor was "Pfizer" with 30 trials, followed by "Eli Lilly and Company" with 16 trials sponsored, "Janssen Vaccines & Prevention B.V." with 10 trials sponsored, "Emergent BioSolutions" with 9 trials sponsored and "Shire" with 9 trials sponsored. Other sponsors include 147 different institutions and companies that sponsored additional 103 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Coastal Carolina Research Center" #1 collaborator was "Biomedical Advanced Research and Development Authority" with 3 trials as a collaborator, "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Department of Health and Human Services" with 2 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator and "Premier Research Group plc" with 2 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Coastal Carolina Research Center" are "Migraine" (14 trials), "Osteoarthritis" (7 trials), "Smoking Cessation" (6 trials), "Depressive Disorder, Major" (5 trials) and "Hot Flashes" (5 trials). Many other conditions were trialed in "Coastal Carolina Research Center" in a lesser frequency.

Most popular intervention types in "Coastal Carolina Research Center" are "Drug" (167 trials), "Biological" (58 trials), "Other" (23 trials), "Behavioral" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (112 trials), "placebo" (9 trials), "Rimegepant" (6 trials), "Ad26.COV2.S" (5 trials) and "Galcanezumab" (5 trials). Other intervention names were less common.

The vast majority of trials in "Coastal Carolina Research Center" are 195 trials for "All" genders, 23 trials for "Female" genders and 8 trials for "Male" genders.

Currently, there are NaN active trials in "Coastal Carolina Research Center". undefined are not yet recruiting, 18 are recruiting, 17 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 171 completed trials in Coastal Carolina Research Center, undefined suspended trials, and 14 terminated clinical trials to date.

Out of the total trials that were conducted in Coastal Carolina Research Center, 14 "Phase 1" clinical trials were conducted, 80 "Phase 2" clinical trials and 127 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 3 trials that are defined as “Not Applicable".